
IXHL Valuation
Incannex Healthcare Inc
- Overview
- Forecast
- Valuation
- Earnings
IXHL Relative Valuation
IXHL's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, IXHL is overvalued; if below, it's undervalued.
Historical Valuation
Incannex Healthcare Inc (IXHL) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -221.54. The fair price of Incannex Healthcare Inc (IXHL) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price:0.53
Fair
-0.36
PE
1Y
3Y
5Y
Trailing
Forward
-1.41
EV/EBITDA
Incannex Healthcare Inc. (IXHL) has a current EV/EBITDA of -1.41. The 5-year average EV/EBITDA is -0.31. The thresholds are as follows: Strongly Undervalued below -1.37, Undervalued between -1.37 and -0.84, Fairly Valued between 0.21 and -0.84, Overvalued between 0.21 and 0.74, and Strongly Overvalued above 0.74. The current Forward EV/EBITDA of -1.41 falls within the Strongly Undervalued range.
-1.05
EV/EBIT
Incannex Healthcare Inc. (IXHL) has a current EV/EBIT of -1.05. The 5-year average EV/EBIT is -204.71. The thresholds are as follows: Strongly Undervalued below -1049.13, Undervalued between -1049.13 and -626.92, Fairly Valued between 217.50 and -626.92, Overvalued between 217.50 and 639.72, and Strongly Overvalued above 639.72. The current Forward EV/EBIT of -1.05 falls within the Historic Trend Line -Fairly Valued range.
60.27
PS
Incannex Healthcare Inc. (IXHL) has a current PS of 60.27. The 5-year average PS is 25947.84. The thresholds are as follows: Strongly Undervalued below -47068.89, Undervalued between -47068.89 and -10560.52, Fairly Valued between 62456.20 and -10560.52, Overvalued between 62456.20 and 98964.56, and Strongly Overvalued above 98964.56. The current Forward PS of 60.27 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/OCF
Incannex Healthcare Inc. (IXHL) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.
0.00
P/FCF
Incannex Healthcare Inc. (IXHL) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.
Incannex Healthcare Inc (IXHL) has a current Price-to-Book (P/B) ratio of 1.97. Compared to its 3-year average P/B ratio of 24.91 , the current P/B ratio is approximately -92.08% higher. Relative to its 5-year average P/B ratio of 83.12, the current P/B ratio is about -97.63% higher. Incannex Healthcare Inc (IXHL) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -33.89%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -28.63% , the current FCF yield is about -100.00% lower.
1.97
P/B
Median3y
24.91
Median5y
83.12
-29.88
FCF Yield
Median3y
-33.89
Median5y
-28.63
Competitors Valuation Multiple
The average P/S ratio for IXHL's competitors is 0.00, providing a benchmark for relative valuation. Incannex Healthcare Inc Corp (IXHL) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of IXHL increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of IXHL in the past 1 year is driven by Unknown.
People Also Watch

GORO
Gold Resource Corp
0.840
USD
+5.13%

VVOS
Vivos Therapeutics Inc
3.380
USD
-1.74%

CXAI
CXApp Inc
0.781
USD
-1.26%

CLPS
CLPS Inc
1.049
USD
-1.96%

XBP
XBP Global Holdings Inc
1.280
USD
+12.28%

TZUP
Thumzup Media Corp
4.490
USD
-2.18%

LEXX
Lexaria Bioscience Corp
1.350
USD
+8.87%

GROW
US Global Investors Inc
2.580
USD
0.00%

RENT
Rent the Runway Inc
4.970
USD
+0.20%
FAQ

Is Incannex Healthcare Inc (IXHL) currently overvalued or undervalued?
Incannex Healthcare Inc (IXHL) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -221.54. The fair price of Incannex Healthcare Inc (IXHL) is between NaN to NaN according to relative valuation methord.

What is Incannex Healthcare Inc (IXHL) fair value?

How does IXHL's valuation metrics compare to the industry average?

What is the current P/B ratio for Incannex Healthcare Inc (IXHL) as of Sep 23 2025?

What is the current FCF Yield for Incannex Healthcare Inc (IXHL) as of Sep 23 2025?

What is the current Forward P/E ratio for Incannex Healthcare Inc (IXHL) as of Sep 23 2025?
